|
Volumn 328, Issue 7438, 2004, Pages 479-480
|
Management of anorexia nervosa revisited
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
NEUROLEPTIC AGENT;
NORADRENALIN UPTAKE INHIBITOR;
OLANZAPINE;
REBOXETINE;
SEROTONIN UPTAKE INHIBITOR;
VENLAFAXINE;
ANOREXIA NERVOSA;
BIOSAFETY;
CHRONIC DISEASE;
CLINICAL TRIAL;
DISEASE SEVERITY;
EATING DISORDER;
EDITORIAL;
EXTRAPYRAMIDAL SYMPTOM;
FOLLOW UP;
GENERAL PRACTITIONER;
HEALTH CARE SYSTEM;
HOSPITAL PATIENT;
HUMAN;
LOW DRUG DOSE;
MORTALITY;
PATIENT CARE;
PHYSICIAN;
PREVALENCE;
PRIORITY JOURNAL;
|
EID: 1442348066
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.328.7438.479 Document Type: Editorial |
Times cited : (9)
|
References (11)
|